This Week in Cell | GenomeWeb

This Week in Cell

A team from the US and UK introduce a mass spec-based proteomic approach known as quantitative temporal viromics, or QTV, that it used for characterizing proteins in the human cytomegalovirus over different stages of infection. The multiplexed tandem-mass-tag-based method identified more than 8,000 cellular proteins in HCMV — a set that includes possible treatment targets and proteins prone to interactions with the innate and adaptive immune pathways in the host.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Beyond Cas9

The Next New Thing

This Week in Nature

Escape From Editing

Pause to Discuss

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.